-
Most Recent
Search Results
240 results for IIJI
Why Gold MUST Go Higher
A possible reassessment of gold as a liquid asset used in capital requirements under Basel III could play a critical role in its pricing movements
JPMorgan Just Bought Bumble (BMBL) Stock. Here’s Why.
Bumble is in the spotlight after JPMorgan reported purchasing 3.5 million shares. BMBL stock has increased by over 60% in the past one month.
INO Stock – A Cure for Cancer? Inovio Hopes So
Inovio Pharmaceuticals Inc (NASDAQ:INO) is a small biotech that could some day wipe out some of humanity’s most crippling diseases. Here’s why you should buy…
Coinbase Cofounder Fred Ehrsam Is Buying COIN Stock. Here’s Why.
Shares of COIN stock are in the spotlight following a massive purchase worth $75 million from Coinbase cofounder Fred Ehrsam.
Which Abbott Is the One to Own Post-Split?
Both offer good prospects, but if you can choose just one, AbbVie — which is the device and diagnostics side — looks a tad more…
Pain Therapeutics Jumps 50% on Promising Remoxy Study (PTIE)
Pain Therapeutics (PTIE) stock is soaring Tuesday after its REMOXY study shows the drug could deter prescription painkiller abuse.
Why Is RiskOn International (ROI) Stock Up 21% Today?
RiskOn International stock is rising higher on Tuesday as investors in ROI shares react to an insider buying shares of the company’s stock.
8 Textiles Apparel & Luxury Goods Stocks to Sell Now
The overall ratings of 8 Textiles Apparel & Luxury Goods stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”)…
Tesla Motors Inc (TSLA) CEO Elon Musk Brushes Off Apple Inc. (AAPL) as Major Threat
Tesla (TSLA) CEO Elon Musk doesn’t think Apple (AAPL) and its electric car plans really threaten his company. In fact, quite the opposite.
Among Biotechs, Cubist Has Held its Own During Recent Downturn
Cubist has had several pieces of good news during the past quarter, including a promotion agreement and a settled patent dispute. However, it still needs…
Is Bank of America Still Broke After Buffett, China Bank Deals?
Yes, the company has raised lots of capital — but while it might be enough to cover Basel III rules, it might not be enough…
3 Infrastructure Stocks Positioned for Potential Government Spending
See how these infrastructure stocks are set to benefit from the infrastructure boom fueled by government spending.
Mess or Success: The BlackBerry Guessing Game
BlackBerry has a lot riding on the success of its new smartphones and operating system, but information around its new Z10 has been enveloped in…
Finish Line Inc (FINL) and WashingtonFirst Bankshares Inc (WFBI) Lead 9 Investor Filings
Finish Line Inc is among the 13G and 13D activist investor filings over the past week
AstraZeneca plc (ADR) (AZN) Stock Tanks on Lung Cancer Drug Disappointment
AstraZeneca(AZN) stock was hit hard Thursday after its new lung cancer drug failed to meet a primary endpoint in a Phase III trial.
3 Retail Stocks to Buy Off the Rack
Retail stocks, especially apparel stocks, are having a bad start to the year. But there are still some worth buying, like these three hidden gems.
No Payday In Sight for Alzheimer’s Drug Stocks
At best, the drugs on the market are stopgap measures. They can’t cure the disease.
Should You Buy Canopy Growth (CGC) Stock Before May 30?
While Canopy Growth is in the news thanks to marijuana’s reclassification proposal, CGC stock carries questions ahead of earnings.
Abbott Labs Spinoff Looks Like the Right Move
Shareholders would likely be better served by the company’s prescription drug business standing alone. Here’s why.
GLSI Stock: Why Greenwich LifeSciences Is Up 2,000% Today
GLSI stock is soaring Wednesday after Greenwich LifeSciences shared promising results from its breast cancer immunothrapy.
How U.S. Legal Reforms Could Send This Cannabis Stock Skywards
Tilray would be a major beneficiary of pro-cannabis legal reforms, and TLRY stock has been so beaten-down that the next move should be up.
10 – 10 of 240 results
